| 发明名称 | Pharmaceutical formulations of gallium salts | ||
| 摘要 | The present invention relates to pharmaceutical formulations containing a pharmaceutically acceptable gallium salt (such as gallium nitrate), a delivery agent, and optionally, one or more chemotherapeutic agents and/or adjunctive chemotherapeutic agents. | ||
| 申请公布号 | US9345725(B2) | 申请公布日期 | 2016.05.24 |
| 申请号 | US200511722618 | 申请日期 | 2005.12.29 |
| 申请人 | EMISPHERE TECHNOLOGIES, INC. | 发明人 | Bender Lewis;Shankar Bavani;O'Shaughnessy Catherina |
| 分类号 | A61K33/24;A61K31/195;A61K31/28;A61K9/00;A61K31/351;A61K47/12;A61K47/18 | 主分类号 | A61K33/24 |
| 代理机构 | Blank Rome LLP | 代理人 | Blank Rome LLP |
| 主权项 | 1. An oral pharmaceutical composition comprising (a) gallium nitrate nonahydrate and (b) a delivery agent selected from N-(8-[2-hydroxybenzoyl]-amino)caprylic acid and pharmaceutically acceptable salts thereof. | ||
| 地址 | Roseland NJ US | ||